E-LIB Suche - Ergebnisse für: Sim, Sung Hoon

1

Clinicopathological Factors Associated with Oncotype DX Ris..:

Song, Ran ; Lee, Dong-Eun ; Lee, Eun-Gyeong...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527468/. , 2023

Link: http://www.ncbi.nlm.nih...

2

Survival advantage of locoregional and systemic therapy in ..:

Imoto, Shigeru ; Wang, Kun ; Bi, Xi-wen...
Breast Cancer, Vol.30 No.3, pp.412-424. , 2023

Link: https://hdl.handle.net/1..

3

Progranulin and Breast Cancer Mortality: 13-Year Follow-Up ..:

Koo, Dong-Hoe ; Lee, Keun Seok ; Sim, Sung Hoon...
info:eu-repo/semantics/altIdentifier/doi/10.2147/BCTT.S406685. , 2023

Link: https://www.dovepress.co..

4

Genomic analysis of plasma circulating tumor DNA in patient..:

Lee, Kyoungmin ; Lee, Jongwon ; Choi, Jungmin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10279711/. , 2023

Link: http://www.ncbi.nlm.nih...

5

Progranulin and Breast Cancer Mortality: 13-Year Follow-Up ..:

Koo, Dong-Hoe ; Lee, Keun Seok ; Sim, Sung Hoon...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112348/. , 2023

Link: http://www.ncbi.nlm.nih...

6

SIX1, a glycolysis related gene, regulates tumor progressio..:

Kim, Ju-Ha ; Song, Woo-Ju ; Park, Yeonju...
doi:10.5281/zenodo.6550921. , 2022

Link: https://zenodo.org/recor..

7

Response Rate and Safety of a Neoadjuvant Pertuzumab, Atezo..:

Ahn, Hee Kyung ; Sim, Sung Hoon ; Suh, Koung Jin...
JAMA oncology, Vol.8 No.9, pp.1271-1277. , 2022

Link: https://hdl.handle.net/1..

8

Phase II study to investigate the efficacy of trastuzumab b..:

Sim, Sung Hoon ; Kim, Jeong Eun ; Kim, Min Hwan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429798/. , 2022

Link: http://www.ncbi.nlm.nih...

9

SMARCA4 Depletion Induces Cisplatin Resistance by Activatin..:

Kim, Jihyun ; Jang, Gyubeom ; Sim, Sung Hoon...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582548/. , 2021

Link: http://www.ncbi.nlm.nih...

10

Clinical Effectiveness of Hypofractionated Proton Beam Ther..:

Kim, Tae Hyun ; Lee, Keun Seok ; Sim, Sung Hoon...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595332/. , 2021

Link: http://www.ncbi.nlm.nih...

11

Updated results from the international phase III ALTTO tria..:

Moreno-Aspitia, Alvaro ; Holmes, Eileen M ; Jackisch, Christian...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103014/. , 2021

Link: http://www.ncbi.nlm.nih...

12

Palbociclib Plus Fulvestrant in Korean Patients from PALOMA..:

Kim, Jee Hyun ; Im, Seock-Ah ; Sim, Sung Hoon...
Journal of Breast Cancer, Vol.24 No.1, pp.97-105. , 2021

Link: https://hdl.handle.net/1..

13

Criteria for identifying residual tumours after neoadjuvant..:

Kim, Yunju ; Sim, Sung Hoon ; Park, Boram...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804856/. , 2021

Link: http://www.ncbi.nlm.nih...

14

The Tumor–Fat Interface Volume of Breast Cancer on Pretreat..:

Cho, Hwan-ho ; Park, Minsu ; Park, Hyunjin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697338/. , 2020

Link: http://www.ncbi.nlm.nih...

15

Randomized Open Labe Phase III Trial of Irinotecan Plus Cap..:

Park, In Hae ; Im, Seock-Ah ; Jung, Kyung Hae...
Cancer Research and Treatment, Vol.51 No.1, pp.43-52. , 2020

Link: https://hdl.handle.net/1..